(23739912), D. E., (23739915), O. T., (22928644), M. E., (23739918), A. K., (23739921), L. A., (23739924), A. A., . . . (112613), L. D. (2025). Ivabradine, a hyperpolarization-activated channel blocker, attenuates mechanical, but not heat, hypersensitivity in hyperglycaemic and normoglycemic rat models of diabetic neuropathy.
Chicago Style (17th ed.) Citation(23739912), Dina Elsayegh, Omar Tluli (23739915), Maram Elzayyat (22928644), Abdelrahman Karen (23739918), Layan Albarghouthi (23739921), Abdulla Al-Emadi (23739924), Mubarak AlMaadid (23739927), Haya Al-Mohannadi (20362818), and Laiche Djouhri (112613). Ivabradine, a Hyperpolarization-activated Channel Blocker, Attenuates Mechanical, but Not Heat, Hypersensitivity in Hyperglycaemic and Normoglycemic Rat Models of Diabetic Neuropathy. 2025.
MLA (9th ed.) Citation(23739912), Dina Elsayegh, et al. Ivabradine, a Hyperpolarization-activated Channel Blocker, Attenuates Mechanical, but Not Heat, Hypersensitivity in Hyperglycaemic and Normoglycemic Rat Models of Diabetic Neuropathy. 2025.